Progression in smoldering Waldenström macroglobulinemia: long-term results

The purpose of this study was to define the risk of progression and survival of patients with smoldering Waldenström macroglobulinemia (SWM). SWM is defined clinically as having a serum monoclonal IgM protein ≥ 3 g/dL and/or ≥ 10% bone marrow lymphoplasmacytic infiltration but no evidence of end-org...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Kyle, Robert A., Benson, Joanne T., Larson, Dirk R., Therneau, Terry M., Dispenzieri, Angela, Kumar, Shaji, Melton, L. Joseph, Rajkumar, S. Vincent
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Hematology 2012
Témata:
Clinical Trials and Observations
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3362362/
https://ncbi.nlm.nih.gov/pubmed/22451426
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2011-10-384768
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky